Journal
ANNALS OF HEMATOLOGY
Volume 91, Issue 6, Pages 863-873Publisher
SPRINGER
DOI: 10.1007/s00277-011-1393-y
Keywords
Chronic lymphocytic leukemia; MYC; Translocation; t(8;14); Burkitt; Prognosis
Categories
Funding
- Stichting tegen Kanker
- Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen
- Katholieke Universiteit Leuven (KUL) Geconcerteerde Onderzoeksacties Mathematical engineering tools for Networks (GOA MaNet)
- KUL Center of Excellence Symbiosys-KUL Center for Computational Systems Biology [CoE EF/05/007]
- Belgian Science Policy Interuniversitaire Attractiepolen [P6/25 (BelSPO IUAP P6/25)]
- Agentschap voor Innovatie door Wetenschap en Technologie (IWT) Strategisch Basisonderzoek-Molecular Karyotyping (SBO-MoKA)
- Federale Overheidsdienst (FOD)-Cancer
Ask authors/readers for more resources
Translocations involving are rare in chronic lymphocytic leukemia (CLL), and up to now, their prognostic significance remains unclear. We report the characteristics of 21 patients with CLL and nine patients with prolymphocytic leukemia (PLL), diagnosed in multiple centers ( = 13), which showed an translocation demonstrated by fluorescence in situ hybridization. The prevalence was estimated to be < 1%. Advanced age and male predominance were observed. Morphological analysis frequently revealed the presence of prolymphocytes. A typical CLL-immunophenotype was found in four of nine cases with PLL. Moreover, CD5 and CD23 were frequently expressed in PLL. The latter findings are atypical for PLL and may suggest transformation or progression of an underlying CLL. translocations were frequently observed with concomitant adverse cytogenetic markers, such as del(11q) ( = 8/30) and/or del(17p)/monosomy 17 ( = 7/30). In addition, the presence of unbalanced translocations ( = 24 in 13/30 cases) and complex karyotype ( = 16/30) were frequent in cases with translocations. Altogether, del(17p)/monosomy 17, del(11q), and/or complex karyotype were observed in 22 of 30 patients. Survival outcome was poor: the median time to treatment was only 5 months, and overall survival (OS) from clinical diagnosis and from genetic detection was 71 and 19 months, respectively. In conclusion, CLL/PLL with translocations is a rare entity, which seems to be associated with adverse prognostic features and unfavorable outcome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available